Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor

Clinical trial NCT00039585 · COMPLETED

Trial details

NCT number: NCT00039585
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Cavity Cancer

Start date: 2002-05-01
Primary completion: 2006-02-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.